The world's premier international congress in cardiovascular medicine
Media Alert: The world's greatest event in cardiology, ESC Congress 2014, will take place in Barcelona, Spain, from 30 August to 3 September, and as ever promises journalists a rich source of front-page news and feature background. This year's event has attracted record submissions for both the new study abstract and late-breaking Hot Line sessions, which, says Professor Keith Fox, Chair of the Congress Programme Committee, will ensure another year of high quality presentations reflecting this year's congress spotlight, "innovation and the heart". (Source: ESC News and Press)
Source: ESC News and Press - June 13, 2014 Category: Cardiology Source Type: news
Register now for the world's premier international congress in cardiovascular medicine
Media Alert: The world's greatest event in cardiology, ESC Congress 2014, will take place in Barcelona, Spain, from 30 August to 3 September, and as ever promises journalists a rich source of front-page news and feature background. This year's event has attracted record submissions for both the new study abstract and late-breaking Hot Line sessions, which, says Professor Keith Fox, Chair of the Congress Programme Committee, will ensure another year of high quality presentations reflecting this year's congress spotlight, "innovation and the heart". (Source: ESC News and Press)
Source: ESC News and Press - June 13, 2014 Category: Cardiology Source Type: news
The 2014 EHRA White Book
Discover the current state of arrhythmia management in European countries in the 2014 EHRA White Book. The book has been released at CARDIOSTIM EHRA EUROPACE 2014.
Topics:
Arrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Resuscitation (Source: ESC News and Press)
Source: ESC News and Press - June 13, 2014 Category: Cardiology Source Type: news
Discover the most anticipated science of the year to be presented at ESC Congress Hot Line Sessions!
ESC Congress is the place to discuss the latest findings of recent clinical trials results, updates and registries.Don't forget to register to attend the world's largest and most influential cardiovascular event! (Source: ESC News and Press)
Source: ESC News and Press - June 13, 2014 Category: Cardiology Source Type: news
Watch the ACCA webinar on Cardiac Arrest
Get an update with key opinion leaders on the definition, epidemiology, etiology and causes of cardiac arrest.
Topics:
Acute Coronary Syndromes (ACS) (Source: ESC News and Press)
Source: ESC News and Press - June 11, 2014 Category: Cardiology Source Type: news
Call for comprehensive inclusion of patient reported outcomes in cardiovascular clinical trials
Patient reported outcomes (PROs) should be comprehensively included in cardiovascular clinical trials using the best available tools, according to leading cardiologists and industry representatives in the Cardiovascular Round Table (CRT). All ESC guideline committees will now systematically consider PROs when making recommendations.
Topics:
Clinical pharmacology (Source: ESC News and Press)
Source: ESC News and Press - June 6, 2014 Category: Cardiology Source Type: news
Europe’s premier basic cardiovascular science meeting - Media Alert
Professor Lina Badimon, FCVB 2014 Chairperson: “This is going to be the best, most important and well attended basic cardiovascular research meeting in Europe. Journalists can expect to hear state of the art developments in the most important areas in the field.”
Professor Barbara Casadei, Chairperson of the ESC Council on Basic Cardiovascular Science: “FCVB provides a glimpse into the future of diagnosing and treating cardiovascular disease. Novel basic science concepts will be presented by high profile international speakers that may revolutionise clinical practice in years to come.”
...
Source: ESC News and Press - June 4, 2014 Category: Cardiology Source Type: news
E- journal of Cardiology Practice Likely features of female coronary artery disease
A woman complaining of chest pains might have a compromised anamnestic record, systolic arterial hypertension, abdominal obesity, diabetes, lipid metabolism disturbances, a habit of smoking, psychosocial factors, plaque erosion and atherosclerosis pathogenetic mechanisms as risk factors.Read here a review of some differences and likely features of female coronary artery disease.
Topics:
Percutaneous Cardiovascular Intervention (PCI) (Source: ESC News and Press)
Source: ESC News and Press - May 16, 2014 Category: Cardiology Source Type: news
E-journal of Cardiology Practice on Secondary prevention of non-cardioembolic stroke
Highlighted for you in this article are the risk factor management and pharmaceutical strategy recommendations for secondary prevention of non-cardioembolic stroke according to the evidence reviewed in the latest dedicated guidelines on the topic (American Heart Association).
Topics:
Stroke, Atrial Fibrillation (Source: ESC News and Press)
Source: ESC News and Press - May 16, 2014 Category: Cardiology Source Type: news
PARADIGM-HF trial stopped early for benefit
The PARADIGM-HF trial has been stopped early for a benefit to patients that was overwhelmingly statistically significant. In the largest ever study of a heart failure treatment, LCZ696 won a head to head comparison with gold standard treatment and improved the primary composite endpoint of cardiovascular death or heart failure hospitalisation, and reduced cardiovascular mortality alone.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 16, 2014 Category: Cardiology Source Type: news
CARDIOSTIM-EHRA EUROPACE 2014 presents the latest research on heart rhythm treatment and devices
The congress will take place from 18-21 June 2014 at the Acropolis Convention Centre in Nice, France. This year marks the first time Cardiostim and EHRA have collaborated to bring the scientific aspects of their respective congresses together. Information on the trial phases of revolutionary technical advances will be discussed, including pacemakers and miniature defibrillators, new catheters with a navigation system based on the magnetic triangulation principle and how genetic factors influence atrial and ventricular fibrillation, heart failure and other rhythm pathologies.
T...
Source: ESC News and Press - May 15, 2014 Category: Cardiology Source Type: news
Prevent premature deaths from heart failure, urges the Heart Failure Association
Awareness of Heart Failure is alarmingly poor among the general public and healthcare professionals alike. Policy initiatives that prioritise heart failure prevention and champion equity of care for all would ease the strain on global healthcare systems and improve outcomes for patients. The HFA is calling for global policy change relating to heart failure. An international white paper has been published, Heart failure: preventing disease and death worldwide.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 15, 2014 Category: Cardiology Source Type: news
Indications for CMR in Children with CHD
The EACVI CMR Section is about to publish in the European Heart Journal-Cardiovascular Imaging an important paper dedicated to Indications for CMR in Children with CHD.
In preview, Dr Emanuela Valsangiacomo, main author of this publication, gives us some insight of what will be covered by this important paper. (Source: ESC News and Press)
Source: ESC News and Press - May 15, 2014 Category: Cardiology Source Type: news
EHRA releases its White Book 2013 EP supplement
You can now access the statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries for free in the EHRA White Book 2013 EP supplement. For example see the impact of new training initiatives, the foundation of working groups and the change in the number of practising centres.
Topics:
Arrhythmias, Atherosclerosis, Sudden Cardiac Death and Resuscitation, Stroke (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news
IN-TIME shows equal benefit of home telemonitoring in ICD and CRT-D patients
Home telemonitoring is equally effective in ICD and CRT-D patients, a subanalysis of the IN-TIME trial has shown. The multicentre trial included 664 patients with chronic heart failure, class II or III New York Heart Association (NYHA) symptoms and left ventricular ejection fraction <35% who were receiving optimal medical therapy. Nearly two-thirds of patients (60%) received a cardiac resynchronisation defibrillator (CRT-D) while 40% received an implantable cardioverter defibrillator (ICD).
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news
